55 related articles for article (PubMed ID: 38656879)
21. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
22. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
[TBL] [Abstract][Full Text] [Related]
24. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.
Keyvani V; Riahi E; Yousefi M; Esmaeili SA; Shafabakhsh R; Moradi Hasan-Abad A; Mahjoubin-Tehran M; Hamblin MR; Mollazadeh S; Mirzaei H
Front Pharmacol; 2022; 13():823572. PubMed ID: 35250573
[TBL] [Abstract][Full Text] [Related]
25. Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds.
Mai H; Xie H; Luo M; Hou J; Chen J; Hou J; Jiang DK
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158838
[TBL] [Abstract][Full Text] [Related]
26. LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma.
Zhang H; Xu K; Xiang Q; Zhao L; Tan B; Ju P; Lan X; Liu Y; Zhang J; Fu Z; Li C; Wang J; Song J; Xiao Y; Cheng Z; Wang Y; Zhang S; Xiang T
Genes Dis; 2022 Jan; 9(1):151-164. PubMed ID: 35005115
[TBL] [Abstract][Full Text] [Related]
27. NUSAP1 promotes the metastasis of breast cancer cells via the AMPK/PPARγ signaling pathway.
Qiu J; Xu L; Zeng X; Wu Z; Wang Y; Wang Y; Yang J; Wu H; Xie Y; Liang F; Lv Q; Du Z
Ann Transl Med; 2021 Nov; 9(22):1689. PubMed ID: 34988198
[TBL] [Abstract][Full Text] [Related]
28. Stemness-associated senescence genes as potential novel risk factors for papillary renal cell carcinoma.
Zhang Y; Liu Y; Hu X; Song F; Zheng S; Zheng X; Sun J; Li L; Huang P
Transl Androl Urol; 2021 Nov; 10(11):4241-4252. PubMed ID: 34984189
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets.
Zhang M; Chen H; Liang B; Wang X; Gu N; Xue F; Yue Q; Zhang Q; Hong J
Front Mol Biosci; 2021; 8():777921. PubMed ID: 34938774
[TBL] [Abstract][Full Text] [Related]
30. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
31. Corrigendum to "PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer".
Li G; Liu G; Wang X
Biomed Res Int; 2021; 2021():9762405. PubMed ID: 34725641
[TBL] [Abstract][Full Text] [Related]
32. New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma
Zhou S; Han Y; Li J; Pi X; Lyu J; Xiang S; Zhou X; Chen X; Wang Z; Yang R
Front Oncol; 2021; 11():745384. PubMed ID: 34722301
[TBL] [Abstract][Full Text] [Related]
33. Metabolic reprogramming in cervical cancer and metabolomics perspectives.
Li B; Sui L
Nutr Metab (Lond); 2021 Oct; 18(1):93. PubMed ID: 34666780
[TBL] [Abstract][Full Text] [Related]
34. Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.
Poturnajova M; Kozovska Z; Matuskova M
Cell Signal; 2021 Nov; 87():110120. PubMed ID: 34428540
[TBL] [Abstract][Full Text] [Related]
35. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma.
He RQ; Li JD; Du XF; Dang YW; Yang LJ; Huang ZG; Liu LM; Liao LF; Yang H; Chen G
Cancer Cell Int; 2021 Aug; 21(1):442. PubMed ID: 34419067
[TBL] [Abstract][Full Text] [Related]
36. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
Lei MML; Lee TKW
Front Cell Dev Biol; 2021; 9():692940. PubMed ID: 34235155
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling.
Liu S; Zhang C; Wang B; Zhang H; Qin G; Li C; Cao L; Gao Q; Ping Y; Zhang K; Lian J; Zhao Q; Wang D; Zhang Z; Zhao X; Yang L; Huang L; Yang B; Zhang Y
Cancer Immunol Immunother; 2021 Sep; 70(9):2601-2616. PubMed ID: 33576874
[TBL] [Abstract][Full Text] [Related]
38. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stemness Meets Immunity: From Mechanism to Therapy.
Chen P; Hsu WH; Han J; Xia Y; DePinho RA
Cell Rep; 2021 Jan; 34(1):108597. PubMed ID: 33406434
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
